+987.9%
MRNA vs EXPD
+53.8%
+934.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXPD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -3.2% | +16.3% | +13.8% |
| 7D | +20.6% | +0.3% | +20.4% | +20.3% |
| 30D | +27.1% | +1.8% | +25.3% | +26.4% |
| 3M | +353.4% | +8.9% | +344.4% | +343.7% |
| 6M | +446.3% | +42.2% | +404.0% | +402.1% |
| YTD | +776.2% | +33.4% | +742.8% | +667.3% |
| 1Y | +987.9% | +47.2% | +940.7% | +792.9% |
| All | +987.9% | +53.8% | +934.1% | +792.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EXPD.
Daily Out/Under-Performance
Portfolio return minus EXPD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXPD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXPD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling